FDA.reportPublic FDA data

bendamustine HCl 45 MG in 0.5 ML Injection

RxCUI
1805015
RxNorm name
bendamustine HCl 45 MG in 0.5 ML Injection
Display name
bendamustine HCl 45 MG in 0.5 ML Injection
Full name
bendamustine HCl 45 MG in 0.5 ML Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:54

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
39d53698-57fa-7c99-fc5b-f52a55684826bendamustine HCl 45 MG in 0.5 ML Injection [PSN] · 0.5 ML bendamustine hydrochloride 90 MG/ML Injection [SCD] · bendamustine hydrochloride 45 MG per 0.5 ML Injection [SY]326These highlights do not include all the information needed to use TREANDA safely and effectively. See full prescribing information for TREANDA. TREANDA ® (bendamustine hydrochloride) injection, for intravenous use TREANDA ® (bendamustine hydrochloride) for injection, for intravenous use Initial U.S. Approval: 200820221027